Director, Portfolio Strategy Inflammation & Immunology
Pfizer
July 03, 2026
Remote friendly (Pennsylvania, United States)
United States
Corporate Functions
Responsibilities:
- Develop and support long-range I&I portfolio strategy and planning across early pipeline, lifecycle opportunities, and emerging disease areas.
- Synthesize scientific/clinical/commercial/access/competitive/patient insights to define portfolio priorities and trade-offs.
- Assess opportunities across near-, mid-, and long-term horizons; translate strategy into leadership-ready recommendations.
- Develop early commercial assessments for assets, indications, mechanisms, and disease opportunities; refine product concepts, TPP inputs, positioning hypotheses, and market archetypes.
- Provide commercial input to clinical development, evidence generation, lifecycle, and indication sequencing.
- Support business development and external innovation assessments (valuation, market sizing, competitive scenarios, strategic fit) and create executive-ready materials.
- Partner cross-functionally and support governance/portfolio review/investment decision forums; influence decisions without direct authority.
- Use AI-enabled tools to improve landscape synthesis, scenario development, and strategy efficiency; ensure responsible/compliant AI usage.
Minimum requirements:
- Bachelor’s +8 years OR Master’s +7 years OR PhD +5+ years.
- Experience in pharma/biotech/life sciences strategy, consulting, corporate strategy, commercial development, business development, forecasting, market research, analytics, or related.
- Strong strategic/analytical skills; ability to synthesize complex inputs into recommendations.
- Experience in portfolio strategy and/or early commercial assessment, business case/opportunity assessment, or cross-functional planning.
- Ability to manage multiple priorities in a matrixed environment; strong communication/organization/problem-solving/stakeholder management.
Preferred:
- I&I/autoimmune/specialty care or complex therapeutic area experience.
- Early commercial strategy/portfolio management/corporate strategy or BD assessment experience.
- Market access, payer, evidence generation, and value demonstration knowledge.
- Comfort with AI-native/AI-augmented environments.
- Discretion and sound judgment.
Work location: Hybrid.
- Develop and support long-range I&I portfolio strategy and planning across early pipeline, lifecycle opportunities, and emerging disease areas.
- Synthesize scientific/clinical/commercial/access/competitive/patient insights to define portfolio priorities and trade-offs.
- Assess opportunities across near-, mid-, and long-term horizons; translate strategy into leadership-ready recommendations.
- Develop early commercial assessments for assets, indications, mechanisms, and disease opportunities; refine product concepts, TPP inputs, positioning hypotheses, and market archetypes.
- Provide commercial input to clinical development, evidence generation, lifecycle, and indication sequencing.
- Support business development and external innovation assessments (valuation, market sizing, competitive scenarios, strategic fit) and create executive-ready materials.
- Partner cross-functionally and support governance/portfolio review/investment decision forums; influence decisions without direct authority.
- Use AI-enabled tools to improve landscape synthesis, scenario development, and strategy efficiency; ensure responsible/compliant AI usage.
Minimum requirements:
- Bachelor’s +8 years OR Master’s +7 years OR PhD +5+ years.
- Experience in pharma/biotech/life sciences strategy, consulting, corporate strategy, commercial development, business development, forecasting, market research, analytics, or related.
- Strong strategic/analytical skills; ability to synthesize complex inputs into recommendations.
- Experience in portfolio strategy and/or early commercial assessment, business case/opportunity assessment, or cross-functional planning.
- Ability to manage multiple priorities in a matrixed environment; strong communication/organization/problem-solving/stakeholder management.
Preferred:
- I&I/autoimmune/specialty care or complex therapeutic area experience.
- Early commercial strategy/portfolio management/corporate strategy or BD assessment experience.
- Market access, payer, evidence generation, and value demonstration knowledge.
- Comfort with AI-native/AI-augmented environments.
- Discretion and sound judgment.
Work location: Hybrid.